Literature DB >> 14985298

Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension.

Gabriele Fuchsjäger-Mayrl1, Beate Wally, Michael Georgopoulos, Georg Rainer, Karl Kircher, Wolf Buehl, Tina Amoako-Mensah, Hans-Georg Eichler, Clemens Vass, Leopold Schmetterer.   

Abstract

PURPOSE: There is evidence that altered optic nerve head (ONH) blood flow may play a role in the development and progression of glaucoma. In the present study, the baseline characteristics were examined in a study population participating in a clinical trial in which the ocular hemodynamic effects of timolol and dorzolamide were compared.
METHODS: One hundred forty patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT) were included in this trial and their baseline parameters compared with those of a group of 102 age-matched control subjects. Scanning laser Doppler flowmetry was used to measure blood flow in the temporal neuroretinal rim and the cup of the ONH. Pulsatile choroidal blood flow was assessed by laser interferometric measurement of fundus pulsation amplitude. In addition, hemodynamic parameters and mean arterial pressure were calculated in both groups.
RESULTS: All ocular hemodynamic parameters were significantly lower in the POAG/OHT group compared with the healthy control group (P < 0.001 each). In addition, a significant positive correlation between laser Doppler flowmetry readings and mean arterial pressure was observed in patients with glaucoma but not in healthy control subjects. Likewise, the correlation coefficient between fundus pulsation amplitude and mean arterial pressure was higher in patients with glaucoma than in healthy control subjects.
CONCLUSIONS: The present study indicates reduced ONH and choroidal blood flow and an abnormal association between blood pressure and ocular perfusion in patients with primary open-angle glaucoma or ocular hypertension, independent of topical antiglaucoma medication. Hence, vascular dysregulation appears to be an early manifestation in glaucoma that is not caused by pharmacologic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985298     DOI: 10.1167/iovs.03-0461

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  77 in total

1.  No apparent association between ocular perfusion pressure and visual field damage in normal-tension glaucoma patients.

Authors:  Naoyuki Kurita; Atsuo Tomidokoro; Chihiro Mayama; Makoto Aihara; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2006-12-18       Impact factor: 2.447

2.  Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma.

Authors:  Yoko Inagaki; Yukihiko Mashima; Tomoyo Funayama; Yuichiro Ohtake; Nobuo Fuse; Noriko Yasuda; Takeo Fukuchi; Akira Murakami; Yoshihiro Hotta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

3.  Noninvasive measurements and analysis of blood velocity profiles in human retinal vessels.

Authors:  Zhangyi Zhong; Hongxin Song; Toco Yuen Ping Chui; Benno L Petrig; Stephen A Burns
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-13       Impact factor: 4.799

4.  Cardiac-Gated En Face Doppler Measurement of Retinal Blood Flow Using Swept-Source Optical Coherence Tomography at 100,000 Axial Scans per Second.

Authors:  ByungKun Lee; WooJhon Choi; Jonathan J Liu; Chen D Lu; Joel S Schuman; Gadi Wollstein; Jay S Duker; Nadia K Waheed; James G Fujimoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

5.  Effect of simulated dynamic intraocular pressure on retinal thickness measured by optical coherence tomography after cataract surgery.

Authors:  Ding Chen; Jun Zhu; Jin Li; Xi-Xia Ding; Fan Lu; Yun-E Zhao
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

Review 6.  Is There Any Role for the Choroid in Glaucoma?

Authors:  Iman Goharian; Mitra Sehi
Journal:  J Glaucoma       Date:  2016-05       Impact factor: 2.503

Review 7.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

Review 8.  Is Estrogen a Therapeutic Target for Glaucoma?

Authors:  Samantha S Dewundara; Janey L Wiggs; David A Sullivan; Louis R Pasquale
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

9.  Prolonged retinal arteriovenous passage time is correlated to ocular perfusion pressure in normal tension glaucoma.

Authors:  Niklas Plange; Marion Kaup; Andreas Remky; Kay Oliver Arend
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-02       Impact factor: 3.117

10.  Circadian blood pressure and intraocular pressure patterns in normal tension glaucoma patients with undisturbed sleep.

Authors:  Yong-Kyu Kim; Won Hyuk Oh; Ki Ho Park; Joon Mo Kim; Dong Myung Kim
Journal:  Korean J Ophthalmol       Date:  2010-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.